MoonLake Immunotherapeutics Class A financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

문레이크 이뮤노테라퓨틱스NASDAQ:MLTX · Nasdaq · Healthcare · sector #17

$10.95-3.78%

2026-10-06 close

MoonLake Immunotherapeutics Class A's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$143M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy